Results: Among the 54,889 stroke survivors, 47,559 (86.65%) live at home, 7,330 (13.35%) live in care institutions
Many reported benefits come from small trials, mechanistic studies, or real-world clinical experience, including our own patient feedback here at MedClub
If NASCOBAL is used for the treatment of anemia concomitantly with chloramphenicol, monitor for reduced efficacy and if needed, consider an alternative therapy Risk Summary The limited available data on NASCOBAL in pregnant women are insufficient to inform a drug-associated risk of adverse developmental outcomes
Parkinsons disease-associated pathogenic VPS35 mutation causes complex I deficits
It is generally accepted that excess cytosolic copper is tightly bound by the metallothioneins, preventing the existence of free, unbound copper ions